LAB & GMP
Ensuring Excellence in Healthcare Innovation
Integrating advanced laboratory services with Good Manufacturing Practices (GMP) to deliver innovative, high-quality, and compliant healthcare solutions.
Clinical Trials and Drug Development
01.
Pharmacogenomics
Testing genetic variations that influence drug response for optimizing drug selection and dosing.
Therapeutic Monitoring
Measuring drug levels in the blood to ensure safety and efficacy in clinical trials.
Adverse Event Analysis
Identifying and validating biomarkers linked to adverse drug reactions.
Clinical Trial Biomarker Testing
Centralized testing to maintain consistency across multicenter trials.
.jpg)
.jpg)
.jpg)
02.
GMP OEM
Stem Cell and Exosome Culturing
Advanced techniques for cultivating stem cells and exosomes under strict GMP standards.
OTC Drug Production
Manufacturing high-quality over-the-counter drugs with compliance to regulatory requirements.
Supplement and Organic Food Production
Developing supplements and healthy organic food products in GMP-certified facilities to ensure safety and quality.
Fertilization Techniques
03.
Conventional IVF
Combining eggs and sperm in a petri dish to enable natural fertilization.
Intracytoplasmic Sperm Injection (ICSI)
Injecting a single sperm directly into an egg, ideal for addressing male infertility issues.
Embryo Monitoring
Observing fertilized eggs as they develop into embryos in controlled lab conditions.
Time-Lapse Imaging
Utilizing advanced imaging to track embryo development stages.
Blastocyst Culture
Cultivating embryos to the blastocyst stage (5–6 days) to enhance implantation success rates.
.jpg)
.jpg)
.jpg)
.jpg)
Cancer Diagnostics and Monitoring
04.
Liquid Biopsies
Detect circulating tumor cells (CTCs) and cell-free DNA (cfDNA) for early cancer detection and real-time treatment monitoring.
Tumor Profiling and Mutation Analysis
Leverage next-generation sequencing (NGS) and advanced technologies to identify tumor characteristics and genetic mutations.
Immunoassays and Molecular Panels
Identify minimal residual disease (MRD) and biomarkers for precise diagnostics and effective treatment planning.
05.
Diagnostics and Disease Monitoring
Molecular Diagnostics
Includes genetic testing, PCR-based assays, and next-generation sequencing (NGS) for detecting genetic mutations, infectious diseases (e.g., COVID-19, HIV), and hereditary conditions.
Immunohistochemistry (IHC)
Used in cancer diagnosis to identify biomarkers and protein expression levels in tissue samples.
Microbiology and Virology
Culturing and testing for bacterial, fungal, and viral pathogens.
Hematology and Coagulation
Tests for blood disorders, including complete blood counts (CBC), clotting factors, and platelet function.
Clinical Chemistry
Analyzing blood and bodily fluids for metabolic, enzymatic, and electrolyte imbalances.
.jpg)
.jpg)
.jpg)
.jpg)
06.
Genomics and Proteomics
Whole-Genome and Whole-Exome Sequencing
Comprehensive genetic analysis to uncover variations and mutations.
RNA Sequencing
Advanced transcriptomic studies to analyze gene expression and regulation.
Proteomics with Mass Spectrometry
Detailed protein expression profiling for insights into cellular functions and disease mechanisms.
Clinical Trials Support
07.
Certified labs play a crucial role in clinical research by providing accurate testing for studies, including:
Phase I-IV Clinical Trials
-
Biomarker identification and validation.
-
Pharmacokinetics (PK) and pharmacodynamics (PD) analysis.
-
Safety monitoring through blood, urine, and other specimen testing.
Companion Diagnostics
-
Tests to determine patient suitability for targeted therapies.
Laboratory-Developed Tests (LDTs)
-
Custom tests for trial-specific biomarkers.
Assay Validation and Standardization
-
Ensuring reproducibility and regulatory compliance in trial data.
.jpg)
.jpg)
